Sandoz.com isn't just a corporate brochure—it's the digital front door for a $4.9B revenue giant that pioneered generic medicines. While most pharma sites drown in regulatory jargon, Sandoz's domain serves 178K monthly visitors with surgical precision, proving that in healthcare, trust isn't built on hype—it's built on access.

"When your brand is 'the leading name in generic and biosimilar,' your website must be as reliable as your supply chain—no hype, just access."

The technology stack reveals a modern, compliance-heavy architecture. Next.js powers the frontend, while OneTrust handles privacy—critical for a global health company navigating GDPR and HIPAA. The absence of a Trustpilot rating isn't a flaw; it's strategic. Sandoz doesn't need social proof because its trust is institutional, built through decades of B2B relationships and regulatory credibility. The site's 32% direct traffic confirms this: professionals bookmark, they don't browse.

• Patient assistance programs drive more search volume than investor relations
• Condition-specific keywords outperform branded drug names in organic search
• Direct traffic (32%) signals high institutional trust and repeat usage
• Next.js + OneTrust stack balances modern UX with regulatory compliance